Quarterly report · Q1
2413.TEDINET S100RK8S
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥57.4bn | 2023-04-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥230.8bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥57.0bn | 2022-04-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥18.0bn | 2023-04-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥18.7bn | 2022-04-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥19.8bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥74.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥19.7bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥12.4bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥49.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥12.1bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥13.6bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥13.5bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥439.6bn | at 2023-06-30 | Cons. | Assets IFRS |
| Total assets | ¥400.6bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥357.5bn | at 2022-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥110.9bn | at 2023-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥91.1bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥328.8bn | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥309.5bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥275.1bn | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥264.0bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥316.8bn | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥302.6bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥268.8bn | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥130.7bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥118.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥88.8bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥104.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥12.0bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥57.1bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥9.4bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥18.2bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥21.9bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥14.7bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥16.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥22.8bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥12.5bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥18.29 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥72.22 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥17.86 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥18.27 | 2023-04-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥72.17 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥17.85 | 2022-04-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 72.1% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 75.5% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 75.2% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥1.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥1.0bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥167m |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥5.6bn |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥5.6bn |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥16m |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥7.0bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥6.8bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥114m |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥21.9bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥21.1bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥868m |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥8.9bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥15.7bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥15.7bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥11m |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.7bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥3m |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥831m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥57.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥56.9bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1.0bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥18.0bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥471m |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥5.5bn |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.2bn |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥267m |
| jpcrp040300-q1r_E05425-000Career Solutionreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.8bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥7.2bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥7.0bn |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥162m |
| jpcrp040300-q1r_E05425-000Evidence Solutionreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.2bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥19.3bn |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥951m |
| jpcrp040300-q1r_E05425-000Medical Platformreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥8.8bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥14.9bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥14.9bn |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2m |
| jpcrp040300-q1r_E05425-000Overseasreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥4.0bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥9.9bn |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥304m |
| jpcrp040300-q1r_E05425-000Site Solutionreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.4bn |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥58.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥56.3bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥19.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 587
| Item | Context | Value | Unit |
|---|---|---|---|
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Voting rights (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)エムスリー株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都港区赤坂一丁目11番44号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Description of fact that consolidated financial statements have been prepared in accordance with IFRS financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Condensed quarterly consolidated statement of financial position IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Condensed year to quarter end consolidated statement of profit or loss IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Condensed year to quarter end consolidated statement of comprehensive income IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Condensed quarterly consolidated statement of changes in equity IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Condensed quarterly consolidated statement of cash flows IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes reporting entity condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes basis of preparation condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant accounting policies condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant accounting estimates and judgements condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes business combinations condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes goodwill condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes share capital and other equity items condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes dividends condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes fair value of financial instruments condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes earnings per share condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes subsequent events condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes approval of condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |